Quantum AI Series: Dr. Hans Melo, CEO of Menten AI - Exclusive Interview by Maëva Ghonda
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Quantum AI Series: Dr. Hans Melo, CEO of Menten AI - Exclusive Interview by Maëva Ghonda
-
Narrated by:
-
By:
About this listen
The Quantum AI Series features exclusive interviews of the global innovators shaping the future of quantum computing. In Episode 4 of Season 2, Maëva Ghonda, the founder and chair of the Quantum AI Institute, interviews Dr. Hans Melo, CEO, Menten AI.
Dr. Hans Melo is co-founder and CEO of Menten AI, Inc., a therapeutics company and leader in quantum computing applications in drug discovery. He holds a PhD in Machine Learning and Computational Neuroscience from the University of Toronto.
Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We develop computational methods for protein design that leverage machine learning and quantum computing.
No reviews yet